Debt-to-equity of GALECTIN THERAPEUTICS INC from 31 Mar 2012 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
GALECTIN THERAPEUTICS INC quarterly Debt-to-equity in % history and change rate from 31 Mar 2012 to 30 Sep 2025.
  • GALECTIN THERAPEUTICS INC Debt-to-equity for the quarter ending 30 Sep 2025 was -110%, a 25% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

GALECTIN THERAPEUTICS INC Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 -110% +36% +25% 30 Sep 2025
Q2 2025 -115% +37% +24% 30 Jun 2025
Q1 2025 -119% +36% +23% 31 Mar 2025
Q4 2024 -137% +2.4% +1.7% 31 Dec 2024
Q3 2024 -147% -4.7% -3.3% 30 Sep 2024
Q2 2024 -152% -4.9% -3.3% 30 Jun 2024
Q1 2024 -156% +10% +6.1% 31 Mar 2024
Q4 2023 -140% +71% +34% 31 Dec 2023
Q3 2023 -142% +192% +58% 30 Sep 2023
Q2 2023 -147% +759% +84% 30 Jun 2023
Q1 2023 -166% -946% -121% 31 Mar 2023
Q4 2022 -211% -431% -196% 31 Dec 2022
Q3 2022 -334% -423% -475% 30 Sep 2022
Q2 2022 -906% -940% -2742% 30 Jun 2022
Q1 2022 781% +764% +4713% 31 Mar 2022
Q4 2021 221% +210% +1989% 31 Dec 2021
Q3 2021 89% +82% +1110% 30 Sep 2021
Q2 2021 34% +28% +487% 30 Jun 2021
Q1 2021 16% +12% +329% 31 Mar 2021
Q4 2020 11% +6.1% +137% 31 Dec 2020
Q3 2020 7.4% +2% +38% 30 Sep 2020
Q2 2020 5.8% -3.2% -36% 30 Jun 2020
Q1 2020 3.8% -20% -84% 31 Mar 2020
Q4 2019 4.4% -30% -87% 31 Dec 2019
Q3 2019 5.3% -48% -90% 30 Sep 2019
Q2 2019 9.1% -108% -92% 30 Jun 2019
Q1 2019 24% -217% -90% 31 Mar 2019
Q4 2018 35% -87% -71% 31 Dec 2018
Q3 2018 53% -16% -23% 30 Sep 2018
Q2 2018 117% +69% +143% 30 Jun 2018
Q1 2018 241% +197% +447% 31 Mar 2018
Q4 2017 122% +86% +236% 31 Dec 2017
Q3 2017 69% +43% +170% 30 Sep 2017
Q2 2017 48% +29% +146% 30 Jun 2017
Q1 2017 44% +31% +227% 31 Mar 2017
Q4 2016 36% +27% +309% 31 Dec 2016
Q3 2016 26% +17% +184% 30 Sep 2016
Q2 2016 20% +12% +163% 30 Jun 2016
Q1 2016 13% +6.4% +90% 31 Mar 2016
Q4 2015 8.9% +1.6% +22% 31 Dec 2015
Q3 2015 9% -1.1% -11% 30 Sep 2015
Q2 2015 7.5% -6.9% -48% 30 Jun 2015
Q1 2015 7.1% -20% -74% 31 Mar 2015
Q4 2014 7.3% +533% 31 Dec 2014
Q3 2014 10% +385% 30 Sep 2014
Q2 2014 14% -6230% -100% 30 Jun 2014
Q1 2014 27% -51% -66% 31 Mar 2014
Q4 2013 -525% -569% -1297% 31 Dec 2013
Q3 2013 -375% -434% -726% 30 Sep 2013
Q2 2013 6244% +6178% +9276% 30 Jun 2013
Q1 2013 78% -14% -15% 31 Mar 2013
Q4 2012 44% 31 Dec 2012
Q3 2012 60% 30 Sep 2012
Q2 2012 67% 30 Jun 2012
Q1 2012 92% 31 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.